| In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China | |
| Li, Tao; Sheng, Meiyan; Gu, Tengzhen; Zhang, Yan; Yirepanjiang, Ailiyaer; Li, Yu | |
| 刊名 | JOURNAL OF THORACIC DISEASE
 |
| 2018 | |
| 卷号 | 10期号:3页码:1370-1376 |
| 关键词 | Acinetobacter baumannii (A. baumannii) multidrug-resistant Acinetobacter baumannii (MDRAB) cefoperazone-sulbactam tigecycline rifampicin |
| DOI | 10.21037/jtd.2018.02.01 |
| URL标识 | 查看原文 |
| 公开日期 | [db:dc_date_available] |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4580367 |
| 专题 | 山东大学 |
| 作者单位 | 1.Shandong Univ, Qilu Hosp, Dept Resp Dis, Jinan 250012, Shandong, Peoples R China. 2.[Sheng, Mei |
| 推荐引用方式 GB/T 7714 | Li, Tao,Sheng, Meiyan,Gu, Tengzhen,et al. In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China[J]. JOURNAL OF THORACIC DISEASE,2018,10(3):1370-1376. |
| APA | Li, Tao,Sheng, Meiyan,Gu, Tengzhen,Zhang, Yan,Yirepanjiang, Ailiyaer,&Li, Yu.(2018).In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China.JOURNAL OF THORACIC DISEASE,10(3),1370-1376. |
| MLA | Li, Tao,et al."In vitro assessment of cefoperazone-sulbactam based combination therapy for multidrug-resistant Acinetobacter baumannii isolates in China".JOURNAL OF THORACIC DISEASE 10.3(2018):1370-1376. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论